"Carbamazepine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.
| Descriptor ID |
D002220
|
| MeSH Number(s) |
D03.633.300.240.127
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Carbamazepine".
Below are MeSH descriptors whose meaning is more specific than "Carbamazepine".
This graph shows the total number of publications written about "Carbamazepine" by people in this website by year, and whether "Carbamazepine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2018 | 1 | 2 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbamazepine" by people in Profiles.
-
LoPinto-Khoury C, Brennan L, Mintzer S. Impact of carbamazepine on vitamin D levels: A meta-analysis. Epilepsy Res. 2021 Dec; 178:106829.
-
Quon RJ, Meisenhelter S, Adamovich-Zeitlin RH, Song Y, Steimel SA, Camp EJ, Testorf ME, MacKenzie TA, Gross RE, Lega BC, Sperling MR, Kahana MJ, Jobst BC. Factors correlated with intracranial interictal epileptiform discharges in refractory epilepsy. Epilepsia. 2021 02; 62(2):481-491.
-
Mintzer S, Dimova S, Zhang Y, Steiniger-Brach B, De Backer M, Chellun D, Roebling R. Effects of lacosamide and carbamazepine on lipids in a randomized trial. Epilepsia. 2020 12; 61(12):2696-2704.
-
Mintzer S, Trinka E, Kraemer G, Chervoneva I, Werhahn KJ. Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly. Epilepsia. 2018 10; 59(10):1899-1907.
-
Pazdera L, Sperling MR, Harvey JH, Sam MC, Strom LA, Blum D, Grinnell T, Cheng H. Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine. Epilepsia. 2018 03; 59(3):704-714.
-
Malatack JJ, Doyle D. A Drug Regimen for Progressive Familial Cholestasis Type 2. Pediatrics. 2018 01; 141(1).
-
French JA, Mintzer S, Perucca E, Blum DE, Cramer JA, Messenheimer JA, Baulac M. Reflections on monotherapy trials for epilepsy - Authors' reply. Lancet Neurol. 2016 06; 15(7):657-658.
-
Mintzer S, Miller R, Shah K, Chervoneva I, Nei M, Skidmore C, Sperling MR. Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein. Epilepsy Behav. 2016 05; 58:127-32.
-
Malas NM, Ortiz-Aguayo R, Meyer V. Development of mania with carbamazepine for treatment of seizure disorder in a 7-year-old boy. J Clin Psychiatry. 2015 Jan; 76(1):e117-8.
-
Kenyon K, Mintzer S, Nei M. Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy. Seizure. 2014 Mar; 23(3):234-6.